Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Doumerc

Showing results (11-20 of 96) with videos related to

Pageof 10
Sort By:
Journal of Gynecology Obstetrics and Human Reproduction|October 12, 2020
Transvaginal minimally invasive approach: An update on safety from an anatomical, anatomopathological and clinical point of viewAriane Weyl, Elodie Chantalat, Gwendoline Daniel, et al.
Molecular Cancer Therapeutics|July 23, 2008
Chemosensitizing effects of sphingosine kinase-1 inhibition in prostate cancer cell and animal modelsDimitri Pchejetski, Nicolas Doumerc, Muriel Golzio, et al.
International Journal of Surgery Case Reports|July 18, 2018
Total intracorporeal robotic renal auto-transplantation: A new minimally invasive approach to preserve the kidney after major ureteral injuriesNicolas Doumerc, Jean-Baptiste Beauval, Mathieu Roumiguié, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 5, 2010
The sphingosine kinase-1 survival pathway is a molecular target for the tumor-suppressive tea and wine polyphenols in prostate cancerLeyre Brizuela, Audrey Dayon, Nicolas Doumerc, et al.
European Journal of Cancer (Oxford, England : 1990)|October 26, 2010
Sphingosine kinase-1 activity and expression in human prostate cancer resection specimensBernard Malavaud, Dimitri Pchejetski, Catherine Mazerolles, et al.
Journal of Nephropathology|August 20, 2016
Treatment of large plasma volumes using specific immunoadsorption to desensitize ABO-incompatible kidney-transplant candidatesLionel Rostaing, Asma Allal, Arnaud Del Bello, et al.
Clinical Transplantation|October 31, 2019
Laparoscopy for living donor left nephrectomy: Comparison of three-dimensional and two-dimensional visionThomas Prudhomme, Mathieu Roumiguié, Thibaut Benoit, et al.
International Urology and Nephrology|March 3, 2017
Predictive model of 1-year postoperative renal function after living donor nephrectomyThibaut Benoit, Xavier Game, Mathieu Roumiguie, et al.
Cancer Research|December 17, 2005
Sphingosine kinase-1 as a chemotherapy sensor in prostate adenocarcinoma cell and mouse modelsDimitri Pchejetski, Muriel Golzio, Elisabeth Bonhoure, et al.
Cancer Research|October 21, 2010
FTY720 (fingolimod) sensitizes prostate cancer cells to radiotherapy by inhibition of sphingosine kinase-1Dmitri Pchejetski, Torsten Bohler, Leyre Brizuela, et al.
Pageof 10

Showing results (11-20 of 96) with videos related to

Sort By:
Pageof 10
Journal of Gynecology Obstetrics and Human Reproduction|October 12, 2020
Transvaginal minimally invasive approach: An update on safety from an anatomical, anatomopathological and clinical point of viewAriane Weyl, Elodie Chantalat, Gwendoline Daniel, et al.
Molecular Cancer Therapeutics|July 23, 2008
Chemosensitizing effects of sphingosine kinase-1 inhibition in prostate cancer cell and animal modelsDimitri Pchejetski, Nicolas Doumerc, Muriel Golzio, et al.
International Journal of Surgery Case Reports|July 18, 2018
Total intracorporeal robotic renal auto-transplantation: A new minimally invasive approach to preserve the kidney after major ureteral injuriesNicolas Doumerc, Jean-Baptiste Beauval, Mathieu Roumiguié, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 5, 2010
The sphingosine kinase-1 survival pathway is a molecular target for the tumor-suppressive tea and wine polyphenols in prostate cancerLeyre Brizuela, Audrey Dayon, Nicolas Doumerc, et al.
European Journal of Cancer (Oxford, England : 1990)|October 26, 2010
Sphingosine kinase-1 activity and expression in human prostate cancer resection specimensBernard Malavaud, Dimitri Pchejetski, Catherine Mazerolles, et al.
Journal of Nephropathology|August 20, 2016
Treatment of large plasma volumes using specific immunoadsorption to desensitize ABO-incompatible kidney-transplant candidatesLionel Rostaing, Asma Allal, Arnaud Del Bello, et al.
Clinical Transplantation|October 31, 2019
Laparoscopy for living donor left nephrectomy: Comparison of three-dimensional and two-dimensional visionThomas Prudhomme, Mathieu Roumiguié, Thibaut Benoit, et al.
International Urology and Nephrology|March 3, 2017
Predictive model of 1-year postoperative renal function after living donor nephrectomyThibaut Benoit, Xavier Game, Mathieu Roumiguie, et al.
Cancer Research|December 17, 2005
Sphingosine kinase-1 as a chemotherapy sensor in prostate adenocarcinoma cell and mouse modelsDimitri Pchejetski, Muriel Golzio, Elisabeth Bonhoure, et al.
Cancer Research|October 21, 2010
FTY720 (fingolimod) sensitizes prostate cancer cells to radiotherapy by inhibition of sphingosine kinase-1Dmitri Pchejetski, Torsten Bohler, Leyre Brizuela, et al.
Pageof 10